AI assistant
ARS Pharmaceuticals, Inc. — Director's Dealing 2024
Jun 8, 2024
32159_dirs_2024-06-07_b4654ac2-3d1d-49fb-a6b7-ae0447b272b4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: ARS Pharmaceuticals, Inc. (SPRY)
CIK: 0001671858
Period of Report: 2024-06-04
Reporting Person: Shah Pratik (N/A)
Reporting Person: Pratik Shah Living Trust dated June 15, 2011 (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-06-04 | Common Stock | J | 2665800 | — | Disposed | 7490404 | Indirect |
Footnotes
F1: The Pratik Shah Living Trust dated June 15, 2011 transferred 1,332,900 shares to The Light Irrevocable Trust #1, of which an adult son of Pratik Shah, M.D. is a beneficiary, and 1,332,900 shares to The Star Irrevocable Trust #1, of which an adult son of Dr. Shah is a beneficiary. Each transfer was made in exchange for trust assets of equal value under an asset substitution power authorized under the terms of each trust.
F2: Pratik Shah, Ph.D. is the trustee of The Pratik Shah Living Trust dated June 15, 2011.